The role of hypoxia in canine cancer

Veterinary and Comparative Oncology

Volumn 6, Issue 4, 2008, Pages 213-223

  Snyder, S A ^a   Dewhirst, M W ^b   Hauck, Marlene L ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Canine; Hypoxia; Resistance; Tumour

Indexed keywords

FLUOROCARBON; PERFLUOROOCTYL BROMIDE;

ANIMAL; ANIMAL DISEASE; CELL HYPOXIA; DOG; DOG DISEASE; METABOLISM; NEOPLASM; PHYSIOLOGY; REVIEW;

ANIMALS; CELL HYPOXIA; DOG DISEASES; DOGS; FLUOROCARBONS; NEOPLASMS;

EID: 63849268772     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2008.00163.x     Document Type: Review

References (96)

1. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. British Journal of Radiology 1953; 26: 638-648.
2. Thomlinson RH and Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. British Journal of Cancer 1955; 9: 539-549.
3. Alper T and Howard-Flanders P. Role of oxygen in modifying the radiosensitivity of E. coli B. Nature 1956; 178: 978-979.
4. Chi J-T, Wang Z, Nuyten DSA, Rodriguez EH, Schaner ME, Salim A, Wang Y, Kristensen GB, Helland Å, Børresen-Dale A-L, Giaccia A, Longaker MT, Hastie T, Yang GP, van de Vijver MJ, Brown BO. Gene expression programs in response to hypoxia: Cell type specificity and prognostic significance in human cancers. PLoS Medicine 2006; 3: E47.
5. Le QT, Denko N and Giaccia AJ. Hypoxic gene expression and metastasis. Cancer and Metastasis Reviews 2004; 23: 293-310.
6. Rofstad EK, Mathiesen B, Henriksen K, Kindem K, Galappathi K. The tumor bed effect: Increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products. Cancer Research 2005; 65: 2387-2396.
7. Brown JM and Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nature Reviews Cancer 2004; 4: 437-447.
8. Cardenas-Navia LI, Secomb TW and Dewhirst MW. Effects of fluctuating oxygenation on tirapazamine efficacy: Theoretical predictions. International Journal of Radiation Oncology, Biology, Physics 2007; 67: 581-586.
9. Brurberg KG, Skogmo HK, Graff BA, Olsen DR, Rofstad EK. Fluctuations in pO2 in poorly and well-oxygenated spontaneous canine tumors before and during fractionated radiation therapy. Radiotherapy and Oncology 2005; 77: 220.
10. Rohrer Bley C, Wergin M, Roos M, Grenacher B, Kaser-Hotz B. Interrelation of directly measured oxygenation levels, erythropoietin and erythropoietin receptor expression in spontaneous canine tumours. European Journal of Cancer 2007; 43: 963.
11. Rohrer-Bley C, Ohlerth S, Roos M, Wergin M, Achermann R, Kaser-Hotz B. Influence of pretreatment polarographically measured oxygenation levels in spontaneous canine tumors treated with radiation therapy. Strahlentherapie und Onkologie 2006; 182: 518.
12. Thrall DE, LaRue SM, Pruitt AF, Case B, Dewhirst MW. Changes in tumour oxygenation during fractionated hyperthermia and radiation therapy in spontaneous canine sarcomas. International Journal of Hyperthermia 2006; 22: 365.
13. Achermann R, Ohlerth S, Fidel J, Gardelle O, Gassmann M, Roos M, Saunders HM, Scheid A, Wergin M, Kaser-Hotz B. Ultrasound guided, pre-radiation oxygen measurements using polarographic oxygen needle electrodes in spontaneous canine soft tissue sarcomas. In Vivo 2002; 16: 431-437.
14. Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR, Dewhirst MW. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Research 1996; 56: 941-943.
15. Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P, Becker A, Adam M, Molls M, Dunst J, Terris DJ, Overgaard J. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiotherapy and Oncology 2005; 77: 18-24.
16. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Research 1996; 56: 4509-4515.
17. Li C-Y, Shan S, Huang Q, Braun RD, Lanzen J, Hu K, Lin P, Dewhirst MW. Initial stages of tumor cell-induced angiogenesis: Evaluation via skin window chambers in rodent models. Journal of the National Cancer Institute 2000; 92: 143-147.
18. Rockwell SC, Kallman R and Fajardo L. Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. Journal of the National Cancer Institute 1972; 49: 735-749.
19. Suit HD and Maeda M. Oxygen effect factor and tumor volume in the C3H mouse mammary carcinoma. A preliminary report. The American Journal of Roentgenology, Radium Therapy and Nuclear Medicine 1966; 96: 177-182.
20. Suit HD and Shalek RJ. Response of anoxic C3H mouse mammary carcinoma isotransplants (1-25 mm 3) to X irradiation. Journal of the National Cancer Institute 1963; 31: 479-495.
21. Koch S, Mayer F, Honecker F, Schittenhelm M and Bokemeyer C. Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro. British Journal of Cancer 2003; 89: 2133-2139.
22. Hussein D, Estlin EJ, Dive C, Makin GWJ. Chronic hypoxia promotes hypoxia-inducible factor-1{alpha}-dependent resistance to etoposide and vincristine in neuroblastoma cells. Molecular Cancer Therapeutics 2006; 5: 2241-2250.
23. Generali D, Berruti A, Brizzi MP, Campo L, Bonardi S, Wigfield S, Bersiga A, Allevi G, Milani M, Aguggini S, Gandolfi V, Pogliotti L, Bottini A, Harris AL, Fox SB. Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer. Clinical Cancer Research 2006; 12: 4562-4568.
24. Sanna K and Rofstad EK. Hypoxia-induced resistance to doxorubicin and methotrexate in human melanoma cell lines in vitro. International Journal of Cancer 1994; 58: 258-262.
25. Song X, Liu X, Chi W, Liu Y, Wei L, Wang X, Yu J. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene. Cancer Chemotherapy and Pharmacology 2006; 58: 776-784.
26. Lanzen J, Braun RD, Klitzman B, Brizel D, Secomb TW, Dewhirst MW. Direct demonstration of instabilities in oxygen concentrations within the extravascular compartment of an experimental tumor. Cancer Research 2006; 66: 2219-2223.
27. Erickson K, Braun RD, Yu D, Lanzen J, Wilson D, Brizel DM, Secomb TW, Biaglow JE, Dewhirst MW. Effect of longitudinal oxygen gradients on effectiveness of manipulation of tumor oxygenation. Cancer Research 2003; 63: 4705-4712.
28. Dewhirst MW, Ong ET, Braun RD, Smith B, Klitzman B, Evans SM, Wilson D. Quantification of longitudinal tissue pO2 gradients in window chamber tumours: Impact on tumour hypoxia. British Journal of Cancer 1999; 79: 1717-1722.
29. Freyer J. Rates of oxygen consumption for proliferating and quiescent cells isolated from multicellular tumor spheroids. Advances in Experimental Medicine and Biology 1994; 345: 335-342.
30. Secomb T, Hsu R, Ong ET, Gross JF and Dewhirst MW. Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors. Acta Oncologica 1995; 34: 313-316.
31. James PE, Grinberg OY, Michaels G, Swartz HM. Intraphagosomal oxygen in stimulated macrophages. Journal of Cellular Physiology 1995; 163: 241-247.
32. Herst PM and Berridge MV. Cell surface oxygen consumption: A major contributor to cellular oxygen consumption in glycolytic cancer cell lines. Biochimica et Biophysica Acta (BBA) - Bioenergetics 2007; 1767: 170-177.
33. Burd R, Lavorgna SN, Daskalakis C, Wachsberger PR, Wahl ML, Biaglow JE, Stevens CW, Leeper DB. Tumor oxygenation and acidification are increased in melanoma xenografts after exposure to hyperglycemia and meta-iodo-benzylguanidine. Radiation Research 2003; 159: 328-335.
34. Tannock IF and Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Research 1989; 49: 4373-4384.
35. Walenta S and Mueller-Klieser WF. Lactate: Mirror and motor of tumor malignancy. Seminars in Radiation Oncology 2004; 14: 267-274.
36. Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, Dewhirst MW, Mueller-Klieser W. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics 2001; 51: 349-353.
37. Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology 2005; 69: 4-10.
38. Dvorak H. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. The New England Journal of Medicine 1986; 315: 1650-1659.
39. Pettersson A, Nagy JA, Brown LF, Sundberg C, Morgan E, Jungles S, Carter R, Krieger JE, Manseau EJ, Harvey VS, Eckelhoefer IA, Feng D, Dvorak AM, Mulligan RC and Dvorak HF. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Laboratory Investigation 2000; 80: 99-115.
40. Cao Y, Li CY, Moeller BJ, Yu D, Zhao Y, Dreher MR, Shan S, Dewhirst MW. Observation of incipient tumor angiogenesis that is independent of hypoxia and hypoxia inducible factor-1 activation. Cancer Research 2005; 65: 5498-5505.
41. Patan S, Munn LL, Tanda S, Roberge S, Jain RK, Jones RC. Vascular morphogenesis and remodeling in a model of tissue repair: Blood vessel formation and growth in the ovarian pedicle after ovariectomy. Circulation Research 2001; 89: 723-731.
42. Patan S, Tanda S, Roberge S, Jones RC, Jain RK, Munn LL. Vascular morphogenesis and remodeling in a human tumor xenograft: Blood vessel formation and growth after ovariectomy and tumor implantation. Circulation Research 2001; 89: 732-739.
43. Kimura H, Braun RD, Ong ET, Hsu R, Secomb TW, Papahadjopoulos D, Hong K, Dewhirst MW. Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Research 1996; 56: 5522-5528.
44. Dewhirst MW, Kimura H, Rehmus SW, Braun RD, Papahadjopoulos D, Hong K and Secomb TW. Microvascular studies on the origins of perfusion-limited hypoxia. British Journal of Cancer Supplement 1996; 27: S247-S251.
45. Rofstad EK, Galappathi K, Mathiesen B and Ruud EB. Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis. Clinical Cancer Research 2007; 13: 1971-1978.
46. Brown J. Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. British Journal of Radiology 1979; 52: 650-656.
47. Martinive P, Defresne F, Bouzin C, Saliez J, Lair F, Gregoire V, Michiels C, Dessy C, Feron O. Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: Implications for anticancer therapies. Cancer Research 2006; 66: 11736-11744.
48. Wilson JL, Burchell J and Grimshaw MJ. Endothelins induce CCR7 expression by breast tumor cells via endothelin receptor a and hypoxia-inducible factor-1. Cancer Research 2006; 66: 11802-11807.
49. Dewhirst MW. Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting. Cancer Research 2007; 67: 854-855.
50. Koumenis C, Wouters BG. "Translating" tumor hypoxia: Unfolded protein response (UPR)-dependent and UPR-independent pathways. Molecular Cancer Research 2006; 4: 423-436.
51. Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM, Schumacker PT. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia. A mechanism of O2 sensing. Journal of Biological Chemistry 2000; 275: 25130-25138.
52. 2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes. Journal of Biological Chemistry 1996; 271: 21793-21797.
53. Mansfield KD, Guzy RD, Pan Y, Young RM, Cash TP, Schumacker PT, Simon MC. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-[alpha] activation. Cell Metabolism 2005; 1: 393-399.
54. Pan Y, Mansfield KD, Bertozzi CC, Rudenko V, Chan DA, Giaccia AJ, Simon MC. Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro. Molecular and Cellular Biology 2007; 27: 912-925.
55. Hutchison GJ, Valentine HR, Loncaster JA, Davidson JA, Hunter RD, Roberts SA, Harris AL, Stratford IJ, Price PM, West CM. Hypoxia-inducible factor 1{alpha} expression as an intrinsic marker of hypoxia: Correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix. Clinical Cancer Research 2004; 10: 8405-8412.
56. Sobhanifar S, Aquino-Parsons C, Stanbridge EJ, Olive P. Reduced expression of hypoxia-inducible factor-1{alpha} in perinecrotic regions of solid tumors. Cancer Research 2005; 65: 7259-7266.
57. Chen C, Pore N, Behrooz A, Ismail-Beigi F, Maity A. Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. Journal of Biological Chemistry 2001; 276: 9519-9525.
58. Wykoff CC, Beasley NJP, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL. Hypoxia-inducible expression of tumor-associated carbonic ahydrases. Cancer Research 2000; 60: 7075-7083.
59. Lu S, Gu X, Hoestje S, Epner DE. Identification of an additional hypoxia responsive element in the glyceraldehyde-3-phosphate dehydrogenase gene promoter. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 2002; 1574: 152.
60. Firth JD, Ebert BL and Ratcliffe PJ. Hypoxic regulation of lactate dehydrogenase A. Journal of Biological Chemistry 1995; 270: 21021-21027.
61. Semenza GL, Jiang B-H, Leung SW, Passantino R, Concordet J-P, Maire P, Giallongo A. Hypoxia response elements in the aldolase A, enolase 1,and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. Journal of Biological Chemistry 1996; 271: 32529-32537.
62. Semenza GL and Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Molecular and Cellular Biology 1992; 12: 5447-5454.
63. Burroughs KD, Oh J, Barrett JC, DiAgustine RP. Phosphatidylinositol 3-kinase and mek1/2 are necessary for insulin-like growth factor-I-induced vascular endothelial growth factor synthesis in prostate epithelial cells: A role for hypoxia-inducible factor-1? Molecular Cancer Research 2003; 1: 312-322.
64. Levy NS, Chung S, Furneaux H, Levy AP. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. Journal of Biological Chemistry 1998; 273: 6417-6423.
65. Jiang B-H, Agani F, Passaniti A, Semenzq GL. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: Involvement of HIF-1 in tumor progression. Cancer Research 1997; 57: 5328-5335.
66. Eoin PC and Cormac TT. Hypoxia-responsive transcription factors. Pflugers Archiv European Journal of Physiology 2005; 450: 363.
67. Semenza GL. Hydroxylation of HIF-1: Oxygen sensing at the molecular level. Physiology 2004; 19: 176-182.
68. Vordermark D, Kaffer A, Riedl S, Katzer A, Flentje M. Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells. International Journal of Radiation Oncology, Biology, Physics 2005; 61: 1197.
69. Cline JM, Thrall D, Page RL, Franko AJ and Raleigh JA. Immunohistochemical detection of a hypoxia marker in spontaneous canine tumours. British Journal of Cancer 1990; 62: 925-931.
70. Cline JM, Rosner GL, Raleigh JA, Thrall DF. Quantification of CCI-103F labeling heterogeneity in canine solid tumors. International Journal of Radiation Oncology, Biology, Physics 1997; 37: 655-662.
71. Zeman E, Calkins DP, Cline JM, Thrall DE and Raleigh JA. The relationship between proliferative and oxygenation status in spontaneous canine tumors. International Journal of Radiation Oncology, Biology, Physics 1993; 27: 891-898.
72. Achermann RE, Ohlerth SM, Rohrer-Bley C, Gassmann M, Inteeworn N, Roos M, Schärz M, Wergin M, Kaser-Holz B. Oxygenation of spontaneous canine tumors during fractionated radiation therapy. Strahlentherapie und Onkologie 2004; 180: 297.
73. Moulder JE and RS. Hypoxic fractions of solid tumors: Experimental techniques, methods of analysis, and a survey of existing data. International Journal of Radiation Oncology, Biology, Physics 1984; 10: 695-712.
74. Denekamp J, Fowler J and Dische S. The proportion of hypoxic cells in a human tumor. International Journal of Radiation Oncology, Biology, Physics 1977; 2: 1227-1228.
75. Chaudary N and Hill R. Hypoxia and metastasis in breast cancer. Breast Disease 2007; 26: 55-64.
76. Knowles HJ and Harris AL. Hypoxia and oxidative stress in breast cancer: hypoxia and tumourigenesis. Breast Cancer Research 2001; 3: 318-322.
77. Vaupel P, Mayer A, Briest S and Höckel M. Hypoxia in breast cancer: role of blood flow, oxygen diffusion distances, and anemia in the development of oxygen depletion. Advances in Experimental Medicine and Biology 2005; 566: 333-342.
78. 2 tension measurements. Cancer Research 1991; 51: 3316-3322.
79. Milosevic M, Chung P, Parker C, Bristow R, Toi A, Panzarella T, Warde P, Catton C, Menard C, Bayley A, Gospodarowicz M and Hill R. Androgen withdrawal in patients reduces prostate cancer hypoxia: Implications for disease progression and radiation response. Cancer Research 2007; 67: 6022-6025.
80. Movsas B, Chapman J, Hanlon AL, Horwitz EM, Pinover WH, Greenberg RE, Stobbe C and Hanks GE. Hypoxia in human prostate carcinoma: An Eppendorf PO2 study. American Journal of Clinical Oncology 2001; 24: 458-461.
81. Francis P, Namlos H, Müller C, Edén P, Fernebro J, Berner JM, Bjerkehagen B, Akerman M, Bendahl PO, Isinger A, Rydholm A, Myklebost O and Nilbert M. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: Hypoxia-induced transcription profile signifies metastatic potential. BMC Genomics 2007; 8: 73.
82. Nordsmark M, Overgaard M and Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiotherapy and Oncology 1996; 41: 31-39.
83. Lyng H, Sundfor K and Rofstad EK. Oxygen tension in human tumours measured with polarographic needle electrodes and its relationship to vascular density, necrosis and hypoxia. Radiotherapy and Oncology 1997; 44: 163-169.
84. Fyles AW, Milosevic M, Wong R, Kavanagh M-C, Pintilie M, Sun A, Chapman W, Levin W, Manchul L, Keane TJ. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiotherapy and Oncology 1998; 48: 149-156.
85. Bennett M, Feldmeier J, Smee R and Milross C. Hyperbaric oxygenation for tumour sensitisation to radiotherapy. Cochrane Database of Systematic Reviews 2005; 4: CD005007.
86. Song CW, Park HJ, Lee CK, Griffin R. Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment. International Journal of Hyperthermia 2005; 21: 761-767.
87. Kim JH, Kim SH, Kolozsvary A, Khil MS. Potentiation of radiation response in human carcinoma cells in vitro and murine fibrosarcoma in vivo by topotecan, an inhibitor of DNA topoisomerase I. International Journal of Radiation Oncology, Biology, Physics 1992; 22: 515-518.
88. Crabtree H. Observations on the carbohydrate metabolism of tumours. Biochemical Journal 1929; 23: 536-545.
89. Crokart N, Jordan BF, Baudelet C, Cron GO, Hotton J, Radermacher K, Grégoire V, Beghein N, Martinire P, Bouzin C, Feron C, Gallez B, Dewhirst MW, Navia IC, Brizel DM, Willett C, Secomb TW. Glucocorticoids modulate tumor radiation response through a decrease in tumor oxygen consumption. Clinical Cancer Research 2007; 13: 630-635.
90. Crokart N, Radermacher K, Jordan BF, Baudelet C, Cron GO, Grégoire V, Beghein N, Bouzin C, Feron O, Gallez B. Tumor radiosensitization by anti-inflammatory drugs: Evidence for a new mechanism involving the oxygen effect. Cancer Research 2005; 65: 7911-7916.
91. Jordan BF, Grégoire V, Demeure RJ, Sonveaux P, Feron O, O'Hara J, Vanhulle VP, Delzenne N, Gallez B. Insulin increases the sensitivity of tumors to irradiation: Involvement of an increase in tumor oxygenation mediated by a nitric oxide-dependent decrease of the tumor cells oxygen consumption. Cancer Research 2002; 62: 3555-3561.
92. Secomb TW, Hsu R and Dewhirst MW. Synergistic effects of hyperoxic gas breathing and reduced oxygen consumption on tumor oxygenation: A theoretical model. International Journal of Radiation Oncology, Biology, Physics 2004; 59: 572.
93. Snyder SA, Lanzen JL, Braun RD, Rosner G, Secomb TW, Biaglow J, Brizel DM, Dewhirst MW. Simultaneous administration of glucose and hyperoxic gas achieves greater improvement in tumor oxygenation than hyperoxic gas alone. International Journal of Radiation Oncology, Biology, Physics 2001; 51: 494.
94. Crile G. Selective destruction of cancers after exposure to heat. Annals of Surgery 1962; 156: 404-407.
95. Thrall DE, LaRue SM, Yu D, Samulski T, Sanders L, Case B, Rosner G, Azuma C, Poulson J, Pruitt AF, Stanley W, Hauck ML, Williams L, Hese P, Dewhirst MW. Thermal dose is related to duration of local control in canine sarcomas treated with thermoradiotherapy. Clinical Cancer Research 2005; 11: 5206-5214.
96. Vujaskovic Z, Poulson JM, Gaskin AA, Thrall DE, Page RL, Charles HC, MacFall JR, Brizel DM, Meyer RE, Prescott DM, Samulski TV and Dewhirst MW. Temperature-dependent changes in physiologic parameters of spontaneous canine soft tissue sarcomas after combined radiotherapy and hyperthermia treatment. International Journal of Radiation Oncology, Biology, Physics 2000; 46: 179-185.